PC1 header corporate Ads

PC1 header corporate Ads

X

Digital content for F. Hoffmann-La Roche

F. HOFFMANN-LA ROCHE

About, Contact Details

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

No Presentations

VIDEO(s)

No Video

DIGITAL CONTENT

3232 News

3232 News

APIs // Active Pharmaceutical Ingredients

164 APIs, 153 USDMF, 11 CEP/COS, 4 JDMF, 10 KDMF, 2 NDC API

DEVELOPMENTS

348 Drug(s) in Development

348 Drug(s) in Development

DOSSIERs // Finished Dosage Formulations

1010 Dossiers, 207 FDA Orange Book, 363 Europe, 79 Canada, 196 Australia, 165 South Africa

INSPECTIONS & REGISTRATIONS

43 FDA, 3 EDQM, 4 GDUFA

Full View Screen

Full Screen View

Roche's manager accuses former chief of pressuring him to lie to regulator

Roche's manager accuses former chief of pressuring him to lie to regulator

IRISHTIMES

25 Nov 2022

Health Canada Authorizes POLIVY for the Treatment of Large B-Cell Lymphoma

Health Canada Authorizes POLIVY for the Treatment of Large B-Cell Lymphoma

BIOSPACE

24 Nov 2022

Senator aims to eliminate biosimilar 'red tape' with proposal

Senator aims to eliminate biosimilar 'red tape' with proposal

Kevin Dunleavy FIERCEPHARMA

23 Nov 2022

AbbVie's Roche-rivaling bispecific gets FDA priority review

AbbVie's Roche-rivaling bispecific gets FDA priority review

Nick Paul Taylor FIERCEBIOTECH

22 Nov 2022

Jnana deepens ties with Roche and grabs a new round of funding

Jnana deepens ties with Roche and grabs a new round of funding

BIOPHARMADIVE

16 Nov 2022

Roche receives FDA Emergency Use Authorization for its high-throughput test

Roche receives FDA Emergency Use Authorization for its high-throughput test

PRESS RELEASE

16 Nov 2022

Trial failures end latest hope for Roche’s Alzheimer’s drug

Trial failures end latest hope for Roche’s Alzheimer’s drug

BIOPHARMADIVE

15 Nov 2022

Roche-backed Bonum bags $93M series A

Roche-backed Bonum bags $93M series A

Gabrielle Masson FIERCEBIOTECH

15 Nov 2022

Roche's gantenerumab fails to slow cognitive decline in key Alzheimer's studies

Roche's gantenerumab fails to slow cognitive decline in key Alzheimer's studies

Ludwig Burger REUTERS

15 Nov 2022

MorphoSys’ Licensing Partner Roche Provides Update on Phase 3 GRADUATE

MorphoSys’ Licensing Partner Roche Provides Update on Phase 3 GRADUATE

ACCESSWIRE

14 Nov 2022

seqens-m-2022-11-21

Access Virtual Booth

Contact Supplier

Send me more info on How To Grow My Business Digitally?

Market Place

Home

Menu

Post Enquiry

Market Place

Search